BMEZ (BlackRock Health Sciences Term Trust) ROE %: 32.06% (As of Dec. 2025) — 1219% Above Median


BMEZ BlackRock Health Sciences Term Trust BMEZ
39 GF Score
Price $15.71
! 4 Warning Signs
View Full Analysis

What is BlackRock Health Sciences Term Trust ROE %?

BlackRock Health Sciences Term Trust BMEZ +1.88% 39 ROE % is 32.06% as of Dec. 2025, which is 1219% above its 10-year median of 2.43. GuruFocus rates BMEZ with a GF Score™ of 39/100. The stock has 4 warning signs investors should review. Among 1,609 Asset Management companies, BlackRock Health Sciences Term Trust ranks better than 56.93% on this metric.

ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. BlackRock Health Sciences Term Trust's annualized net income for the quarter that ended in Dec. 2025 was $324.9 Mil. BlackRock Health Sciences Term Trust's average Total Stockholders Equity over the quarter that ended in Dec. 2025 was $1,013.5 Mil. Therefore, BlackRock Health Sciences Term Trust's annualized ROE % for the quarter that ended in Dec. 2025 was 32.06%.

The historical rank and industry rank for BlackRock Health Sciences Term Trust's ROE % or its related term are showing as below:

BMEZ' s ROE % Range Over the Past 10 Years
Min: -27.1   Med: 2.43   Max: 37.85
Current: 8.12

During the past 6 years, BlackRock Health Sciences Term Trust's highest ROE % was 37.85%. The lowest was -27.10%. And the median was 2.43%.

BMEZ's ROE % is ranked better than
56.93% of 1609 companies
in the Asset Management industry
Industry Median: 6.52 vs BMEZ: 8.12

BlackRock Health Sciences Term Trust  (NYSE:BMEZ) ROE % Explanation

ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.

The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:

ROE %(Q: Dec. 2025 )
=Net Income/Total Stockholders Equity
=324.88/1013.453
=(Net Income / Revenue )*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(324.88 / 326.174)*(326.174 / 1026.945)*(1026.945 / 1013.453)
=Net Margin %*Asset Turnover*Equity Multiplier
=99.6 %*0.3176*1.0133
=ROA %*Equity Multiplier
=31.63 %*1.0133
=32.06 %

With this breakdown, it is clear that if a company grows its Net Profit Margin, its Asset Turnover, or its Leverage, it can grow its ROE %.

The factors that affect a company's ROE % can also be illustrated with the five-step DuPont Analysis:

ROE %(Q: Dec. 2025 )
=Net Income/Total Stockholders Equity
=324.88/1013.453
=(Net Income / Pre-Tax Income) * (Pre-Tax Income / Revenue) * (Revenue / Total Assets) * (Total Assets / Total Stockholders Equity)
= (324.88 / 324.88) * (324.88 / 326.174) * (326.174 / 1026.945) * (1026.945 / 1013.453)
= Tax Burden * Pretax Margin % * Asset Turnover * Equity Multiplier
= 1 * 99.6 % * 0.3176 * 1.0133
=32.06 %

Note: The net income data used here is two times the semi-annual (Dec. 2025) net income data. The Revenue data used here is two times the semi-annual (Dec. 2025) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net Income is used.

Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.


BlackRock Health Sciences Term Trust ROE % Related Terms


BlackRock Health Sciences Term Trust ROE % Historical Data

* Premium members only.

The historical data trend for BlackRock Health Sciences Term Trust's ROE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BlackRock Health Sciences Term Trust ROE % Chart

BlackRock Health Sciences Term Trust Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROE %
Get a 7-Day Free Trial -8.93 -27.10 3.52 1.33 7.31

BlackRock Health Sciences Term Trust Semi-Annual Data
Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
ROE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only -5.28 3.15 -0.68 -9.54 32.06

BMEZ vs BTZ, AIO, NRK: ROE % Comparison

For the Asset Management subindustry, BlackRock Health Sciences Term Trust's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BlackRock Health Sciences Term Trust ROE % vs Asset Management Industry

For the Asset Management industry and Financial Services sector, BlackRock Health Sciences Term Trust's ROE % distribution charts can be found below:

* The bar in red indicates where BlackRock Health Sciences Term Trust's ROE % falls into.


BMEZ
39GF Score
BlackRock Health Sciences Term Trust BMEZ
ROE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

BlackRock Health Sciences Term Trust ROE % Calculation

BlackRock Health Sciences Term Trust's annualized ROE % for the fiscal year that ended in Dec. 2025 is calculated as

ROE %=Net Income (A: Dec. 2025 )/( (Total Stockholders Equity (A: Dec. 2024 )+Total Stockholders Equity (A: Dec. 2025 ))/ count )
=99.937/( (1663.882+1068.889)/ 2 )
=99.937/1366.3855
=7.31 %

BlackRock Health Sciences Term Trust's annualized ROE % for the quarter that ended in Dec. 2025 is calculated as

ROE %=Net Income (Q: Dec. 2025 )/( (Total Stockholders Equity (Q: Jun. 2025 )+Total Stockholders Equity (Q: Dec. 2025 ))/ count )
=324.88/( (958.017+1068.889)/ 2 )
=324.88/1013.453
=32.06 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is two times the semi-annual (Dec. 2025) net income data. ROE % is displayed in the 30-year financial page.

Frequently Asked Questions Learn more about ROE % →
What does a ROE % of 32.06% mean?
BlackRock Health Sciences Term Trust (BMEZ) has a ROE % of 32.06% as of Dec. 2025. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on BlackRock Health Sciences Term Trust and its competitors. This is 1219% above median its historical median of 2.43. According to the industry distribution chart, BlackRock Health Sciences Term Trust ranks #693 out of 1609 companies in the Asset Management industry, placing it in the top 43.1%.
Is BlackRock Health Sciences Term Trust's ROE % too high?
BlackRock Health Sciences Term Trust's current ROE % of 32.06% is 1219% above median its 10-year median of 2.43. The Asset Management industry median ROE % is 6.52. BlackRock Health Sciences Term Trust's value of 32.06% is 391.7% above this industry median. Based on the distribution chart, BlackRock Health Sciences Term Trust ranks #693 out of 1609 companies in the Asset Management industry, which is above the industry midpoint. Overall, BlackRock Health Sciences Term Trust has a GF Score™ of 39/100, reflecting its overall financial health beyond just this single metric.
How does BlackRock Health Sciences Term Trust's ROE % compare to BTZ and AIO?
According to the Asset Management industry distribution chart, BlackRock Health Sciences Term Trust ranks #693 out of 1609 companies for ROE %. This puts BlackRock Health Sciences Term Trust in the upper half of its industry. The industry median ROE % is 6.52. BlackRock Health Sciences Term Trust's value of 32.06% is 391.7% above this benchmark. While the company's 10-year median is 2.43 vs. the industry median of 6.52, BlackRock Health Sciences Term Trust has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % for an Asset Management company?
The median ROE % among Asset Management companies is 6.52, based on 1,609 companies in the industry. Companies in the top quartile (top 25%) have a ROE % significantly above this median, while those in the bottom quartile fall well below. However, ROE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. BlackRock Health Sciences Term Trust's current ROE % of 32.06% is 391.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % mean?
A high ROE % can signal that a stock is expensive relative to its fundamentals. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on BlackRock Health Sciences Term Trust and its competitors. For the Asset Management industry, the median ROE % is 6.52 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. BlackRock Health Sciences Term Trust's current ROE % is 32.06%, which is 1219% above median its own 10-year median of 2.43. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BlackRock Health Sciences Term Trust stock overvalued right now?
BlackRock Health Sciences Term Trust (BMEZ) has a current ROE % of 32.06%. The current ROE % is 32.06%, which is 1219% above median its 10-year median of 2.43 and 391.7% above the Asset Management industry median of 6.52. BlackRock Health Sciences Term Trust's overall GF Score™ is 39/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % calculated?
ROE % is calculated from a company's financial statements. For BlackRock Health Sciences Term Trust (BMEZ), the current ROE % is 32.06% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

BlackRock Health Sciences Term Trust Business Description

Address 100 Bellevue Parkway, Wilmington, DE, USA, 19809
BlackRock Health Sciences Term Trust is a closed-end fund focused on the healthcare and health sciences sector. Its investment objectives are to provide total return and income through long-term capital appreciation.
39GF Score

Get the complete analysis for BMEZ

ROE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$15.71
Price